| 1 | | GO:0006310 | DNA recombination | 11 | 388 | 0 | 555 | 6.32e-05 | 0.03 | 0.00 | bZero |
| 2 | | GO:0006955 | immune response | 18 | 381 | 62 | 493 | 2.11e-04 | 0.05 | 0.11 | 0.4 |
| 3 | | GO:0006281 | DNA repair | 21 | 378 | 7 | 548 | 3.64e-04 | 0.05 | 0.01 | 4.2 |
| 4 | | GO:0006629 | lipid metabolic process | 5 | 394 | 30 | 525 | 6.78e-04 | 0.01 | 0.05 | 0.2 |
| 5 | | GO:0006508 | proteolysis | 10 | 389 | 41 | 514 | 7.24e-04 | 0.03 | 0.07 | 0.3 |
| 6 | | GO:0007267 | cell\-cell signaling | 18 | 381 | 55 | 500 | 1.91e-03 | 0.05 | 0.10 | 0.5 |
| 7 | | GO:0007186 | G\-protein coupled receptor protein signaling pathway | 15 | 384 | 46 | 509 | 4.68e-03 | 0.04 | 0.08 | 0.5 |
| 8 | | GO:0007165 | signal transduction | 66 | 333 | 133 | 422 | 5.96e-03 | 0.17 | 0.24 | 0.7 |
| 9 | | GO:0007131 | meiotic recombination | 5 | 394 | 0 | 555 | 1.26e-02 | 0.01 | 0.00 | bZero |
| 10 | | GO:0000724 | double\-strand break repair via homologous recombination | 5 | 394 | 0 | 555 | 1.26e-02 | 0.01 | 0.00 | bZero |
| 11 | | GO:0006954 | inflammatory response | 21 | 378 | 53 | 502 | 1.43e-02 | 0.05 | 0.10 | 0.6 |
| 12 | | GO:0045087 | innate immune response | 2 | 397 | 14 | 541 | 1.94e-02 | 0.01 | 0.03 | 0.2 |
| 13 | | GO:0006979 | response to oxidative stress | 24 | 375 | 16 | 539 | 2.13e-02 | 0.06 | 0.03 | 2.1 |
| 14 | | GO:0006750 | glutathione biosynthetic process | 4 | 395 | 0 | 555 | 3.03e-02 | 0.01 | 0.00 | bZero |
| 15 | | GO:0007275 | multicellular organismal development | 20 | 379 | 49 | 506 | 3.06e-02 | 0.05 | 0.09 | 0.6 |
| 16 | | GO:0007155 | cell adhesion | 15 | 384 | 39 | 516 | 3.33e-02 | 0.04 | 0.07 | 0.5 |
| 17 | | GO:0007049 | cell cycle | 23 | 376 | 17 | 538 | 4.89e-02 | 0.06 | 0.03 | 1.9 |
| 18 | | GO:0007420 | brain development | 9 | 390 | 4 | 551 | 5.09e-02 | 0.02 | 0.01 | 3.1 |
| 19 | | GO:0007596 | blood coagulation | 1 | 398 | 9 | 546 | 5.19e-02 | 0.00 | 0.02 | 0.2 |
| 20 | | GO:0006302 | double\-strand break repair | 10 | 389 | 5 | 550 | 6.40e-02 | 0.03 | 0.01 | 2.8 |
| 21 | | GO:0006935 | chemotaxis | 8 | 391 | 24 | 531 | 6.69e-02 | 0.02 | 0.04 | 0.5 |
| 22 | | GO:0032981 | mitochondrial respiratory chain complex I assembly | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 23 | | GO:0006303 | double\-strand break repair via nonhomologous end joining | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 24 | | GO:0060048 | cardiac muscle contraction | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 25 | | GO:0007126 | meiosis | 6 | 393 | 2 | 553 | 7.41e-02 | 0.02 | 0.00 | 4.2 |
| 26 | | GO:0006260 | DNA replication | 11 | 388 | 6 | 549 | 7.97e-02 | 0.03 | 0.01 | 2.6 |
| 27 | | GO:0000723 | telomere maintenance | 5 | 394 | 1 | 554 | 8.78e-02 | 0.01 | 0.00 | 7.0 |
| 28 | | GO:0008284 | positive regulation of cell proliferation | 13 | 386 | 32 | 523 | 8.80e-02 | 0.03 | 0.06 | 0.6 |
| 29 | | GO:0019221 | cytokine and chemokine mediated signaling pathway | 4 | 395 | 14 | 541 | 9.72e-02 | 0.01 | 0.03 | 0.4 |
| 30 | | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2 | 397 | 9 | 546 | 1.33e-01 | 0.01 | 0.02 | 0.3 |
| 31 | | GO:0008015 | blood circulation | 2 | 397 | 9 | 546 | 1.33e-01 | 0.01 | 0.02 | 0.3 |
| 32 | | GO:0006284 | base\-excision repair | 5 | 394 | 2 | 553 | 1.36e-01 | 0.01 | 0.00 | 3.5 |
| 33 | | GO:0006471 | protein amino acid ADP\-ribosylation | 5 | 394 | 2 | 553 | 1.36e-01 | 0.01 | 0.00 | 3.5 |
| 34 | | GO:0008380 | RNA splicing | 5 | 394 | 2 | 553 | 1.36e-01 | 0.01 | 0.00 | 3.5 |
| 35 | | GO:0008285 | negative regulation of cell proliferation | 12 | 387 | 28 | 527 | 1.41e-01 | 0.03 | 0.05 | 0.6 |
| 36 | | GO:0001525 | angiogenesis | 12 | 387 | 28 | 527 | 1.41e-01 | 0.03 | 0.05 | 0.6 |
| 37 | | GO:0006457 | protein folding | 17 | 382 | 14 | 541 | 1.43e-01 | 0.04 | 0.03 | 1.7 |
| 38 | | GO:0005975 | carbohydrate metabolic process | 11 | 388 | 7 | 548 | 1.46e-01 | 0.03 | 0.01 | 2.2 |
| 39 | | GO:0006869 | lipid transport | 1 | 398 | 7 | 548 | 1.49e-01 | 0.00 | 0.01 | 0.2 |
| 40 | | GO:0016049 | cell growth | 1 | 398 | 7 | 548 | 1.49e-01 | 0.00 | 0.01 | 0.2 |
| 41 | | GO:0008203 | cholesterol metabolic process | 1 | 398 | 7 | 548 | 1.49e-01 | 0.00 | 0.01 | 0.2 |
| 42 | | GO:0007004 | telomere maintenance via telomerase | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 43 | | GO:0006289 | nucleotide\-excision repair | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 44 | | GO:0042136 | neurotransmitter biosynthetic process | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 45 | | GO:0006470 | protein amino acid dephosphorylation | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 46 | | GO:0048015 | phosphoinositide\-mediated signaling | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 47 | | GO:0006259 | DNA metabolic process | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 48 | | GO:0006139 | nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 49 | | GO:0006397 | mRNA processing | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 50 | | GO:0001501 | skeletal development | 3 | 396 | 11 | 544 | 1.72e-01 | 0.01 | 0.02 | 0.4 |
| 51 | | GO:0040012 | regulation of locomotion | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 52 | | GO:0006275 | regulation of DNA replication | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 53 | | GO:0008053 | mitochondrial fusion | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 54 | | GO:0010248 | establishment and/or maintenance of transmembrane electrochemical gradient | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 55 | | GO:0000075 | cell cycle checkpoint | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 56 | | GO:0006534 | cysteine metabolic process | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 57 | | GO:0006536 | glutamate metabolic process | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 58 | | GO:0051900 | regulation of mitochondrial depolarization | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 59 | | GO:0000019 | regulation of mitotic recombination | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 60 | | GO:0009888 | tissue development | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 61 | | GO:0048478 | replication fork protection | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 62 | | GO:0009062 | fatty acid catabolic process | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 63 | | GO:0006312 | mitotic recombination | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 64 | | GO:0006414 | translational elongation | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 65 | | GO:0006783 | heme biosynthetic process | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 66 | | GO:0006829 | zinc ion transport | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 67 | | GO:0001539 | ciliary or flagellar motility | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 68 | | GO:0008585 | female gonad development | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 69 | | GO:0006325 | establishment and/or maintenance of chromatin architecture | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 70 | | GO:0042035 | regulation of cytokine biosynthetic process | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 71 | | GO:0006590 | thyroid hormone generation | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 72 | | GO:0051881 | regulation of mitochondrial membrane potential | 6 | 393 | 3 | 552 | 1.76e-01 | 0.02 | 0.01 | 2.8 |
| 73 | | GO:0042981 | regulation of apoptosis | 17 | 382 | 15 | 540 | 2.05e-01 | 0.04 | 0.03 | 1.6 |
| 74 | | GO:0007010 | cytoskeleton organization and biogenesis | 2 | 397 | 8 | 547 | 2.07e-01 | 0.01 | 0.01 | 0.3 |
| 75 | | GO:0008635 | caspase activation via cytochrome c | 7 | 392 | 4 | 551 | 2.17e-01 | 0.02 | 0.01 | 2.4 |
| 76 | | GO:0051402 | neuron apoptosis | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 77 | | GO:0006099 | tricarboxylic acid cycle | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 78 | | GO:0006825 | copper ion transport | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 79 | | GO:0008104 | protein localization | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 80 | | GO:0008629 | induction of apoptosis by intracellular signals | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 81 | | GO:0006520 | amino acid metabolic process | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 82 | | GO:0042325 | regulation of phosphorylation | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 83 | | GO:0048146 | positive regulation of fibroblast proliferation | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 84 | | GO:0043066 | negative regulation of apoptosis | 15 | 384 | 13 | 542 | 2.44e-01 | 0.04 | 0.02 | 1.6 |
| 85 | | GO:0006350 | transcription | 23 | 376 | 43 | 512 | 2.47e-01 | 0.06 | 0.08 | 0.7 |
| 86 | | GO:0007229 | integrin\-mediated signaling pathway | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 87 | | GO:0050679 | positive regulation of epithelial cell proliferation | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 88 | | GO:0006879 | cellular iron ion homeostasis | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 89 | | GO:0007243 | protein kinase cascade | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 90 | | GO:0009411 | response to UV | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 91 | | GO:0045786 | negative regulation of cell cycle | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 92 | | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 14 | 385 | 29 | 526 | 2.68e-01 | 0.04 | 0.05 | 0.7 |
| 93 | | GO:0007283 | spermatogenesis | 8 | 391 | 6 | 549 | 2.81e-01 | 0.02 | 0.01 | 1.9 |
| 94 | | GO:0043524 | negative regulation of neuron apoptosis | 8 | 391 | 6 | 549 | 2.81e-01 | 0.02 | 0.01 | 1.9 |
| 95 | | GO:0006120 | mitochondrial electron transport\, NADH to ubiquinone | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 96 | | GO:0008217 | regulation of blood pressure | 7 | 392 | 16 | 539 | 2.93e-01 | 0.02 | 0.03 | 0.6 |
| 97 | | GO:0045941 | positive regulation of transcription | 7 | 392 | 16 | 539 | 2.93e-01 | 0.02 | 0.03 | 0.6 |
| 98 | | GO:0009887 | organ morphogenesis | 7 | 392 | 16 | 539 | 2.93e-01 | 0.02 | 0.03 | 0.6 |
| 99 | | GO:0006006 | glucose metabolic process | 9 | 390 | 7 | 548 | 3.08e-01 | 0.02 | 0.01 | 1.8 |
| 100 | | GO:0006916 | anti\-apoptosis | 33 | 366 | 36 | 519 | 3.12e-01 | 0.08 | 0.06 | 1.3 |
| 101 | | GO:0043496 | regulation of protein homodimerization activity | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 102 | | GO:0043497 | regulation of protein heterodimerization activity | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 103 | | GO:0008637 | apoptotic mitochondrial changes | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 104 | | GO:0030001 | metal ion transport | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 105 | | GO:0010165 | response to X\-ray | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 106 | | GO:0010332 | response to gamma radiation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 107 | | GO:0006268 | DNA unwinding during replication | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 108 | | GO:0030503 | regulation of cell redox homeostasis | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 109 | | GO:0006342 | chromatin silencing | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 110 | | GO:0006476 | protein amino acid deacetylation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 111 | | GO:0016311 | dephosphorylation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 112 | | GO:0048008 | platelet\-derived growth factor receptor signaling pathway | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 113 | | GO:0000077 | DNA damage checkpoint | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 114 | | GO:0046854 | phosphoinositide phosphorylation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 115 | | GO:0007173 | epidermal growth factor receptor signaling pathway | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 116 | | GO:0006118 | electron transport | 34 | 365 | 37 | 518 | 3.17e-01 | 0.09 | 0.07 | 1.3 |
| 117 | | GO:0006936 | muscle contraction | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 118 | | GO:0009611 | response to wounding | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 119 | | GO:0019882 | antigen processing and presentation | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 120 | | GO:0007586 | digestion | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 121 | | GO:0009615 | response to virus | 5 | 394 | 13 | 542 | 3.35e-01 | 0.01 | 0.02 | 0.5 |
| 122 | | GO:0006810 | transport | 39 | 360 | 44 | 511 | 3.52e-01 | 0.10 | 0.08 | 1.2 |
| 123 | | GO:0006468 | protein amino acid phosphorylation | 32 | 367 | 36 | 519 | 3.74e-01 | 0.08 | 0.06 | 1.2 |
| 124 | | GO:0006968 | cellular defense response | 3 | 396 | 8 | 547 | 3.76e-01 | 0.01 | 0.01 | 0.5 |
| 125 | | GO:0007242 | intracellular signaling cascade | 19 | 380 | 34 | 521 | 3.93e-01 | 0.05 | 0.06 | 0.8 |
| 126 | | GO:0007159 | leukocyte adhesion | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 127 | | GO:0045123 | cellular extravasation | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 128 | | GO:0042157 | lipoprotein metabolic process | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 129 | | GO:0008632 | apoptotic program | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 130 | | GO:0050729 | positive regulation of inflammatory response | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 131 | | GO:0042088 | T\-helper 1 type immune response | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 132 | | GO:0030301 | cholesterol transport | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 133 | | GO:0009409 | response to cold | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 134 | | GO:0040007 | growth | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 135 | | GO:0007179 | transforming growth factor beta receptor signaling pathway | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 136 | | GO:0045766 | positive regulation of angiogenesis | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 137 | | GO:0008544 | epidermis development | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 138 | | GO:0006958 | complement activation\, classical pathway | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 139 | | GO:0019370 | leukotriene biosynthetic process | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 140 | | GO:0008202 | steroid metabolic process | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 141 | | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 142 | | GO:0001956 | positive regulation of neurotransmitter secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 143 | | GO:0048169 | regulation of long\-term neuronal synaptic plasticity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 144 | | GO:0048489 | synaptic vesicle transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 145 | | GO:0030644 | cellular chloride ion homeostasis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 146 | | GO:0000002 | mitochondrial genome maintenance | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 147 | | GO:0015866 | ADP transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 148 | | GO:0051935 | glutamate uptake during transmission of nerve impulse | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 149 | | GO:0007252 | I\-kappaB phosphorylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 150 | | GO:0009437 | carnitine metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 151 | | GO:0043071 | positive regulation of non\-apoptotic programmed cell death | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 152 | | GO:0031668 | cellular response to extracellular stimulus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 153 | | GO:0042326 | negative regulation of phosphorylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 154 | | GO:0006010 | glucose 6\-phosphate utilization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 155 | | GO:0006098 | pentose\-phosphate shunt | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 156 | | GO:0016188 | synaptic vesicle maturation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 157 | | GO:0048499 | synaptic vesicle membrane organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 158 | | GO:0005997 | xylulose metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 159 | | GO:0042732 | D\-xylose metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 160 | | GO:0006519 | amino acid and derivative metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 161 | | GO:0006540 | glutamate decarboxylation to succinate | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 162 | | GO:0019752 | carboxylic acid metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 163 | | GO:0018352 | protein\-pyridoxal\-5\-phosphate linkage | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 164 | | GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 165 | | GO:0007292 | female gamete generation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 166 | | GO:0010212 | response to ionizing radiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 167 | | GO:0009620 | response to fungus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 168 | | GO:0010046 | response to mycotoxin | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 169 | | GO:0007207 | muscarinic acetylcholine receptor\, phospholipase C activating pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 170 | | GO:0048754 | branching morphogenesis of a tube | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 171 | | GO:0051048 | negative regulation of secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 172 | | GO:0001302 | replicative cell aging | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 173 | | GO:0010259 | multicellular organismal aging | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 174 | | GO:0035315 | hair cell differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 175 | | GO:0000717 | nucleotide\-excision repair\, DNA duplex unwinding | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 176 | | GO:0033683 | nucleotide\-excision repair\, DNA incision | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 177 | | GO:0006283 | transcription\-coupled nucleotide\-excision repair | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 178 | | GO:0044255 | cellular lipid metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 179 | | GO:0006684 | sphingomyelin metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 180 | | GO:0046513 | ceramide biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 181 | | GO:0018279 | protein amino acid N\-linked glycosylation via asparagine | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 182 | | GO:0006496 | protein amino acid terminal N\-glycosylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 183 | | GO:0034097 | response to cytokine stimulus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 184 | | GO:0019852 | L\-ascorbic acid metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 185 | | GO:0031397 | negative regulation of protein ubiquitination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 186 | | GO:0046685 | response to arsenic | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 187 | | GO:0009410 | response to xenobiotic stimulus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 188 | | GO:0006307 | DNA dealkylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 189 | | GO:0007176 | regulation of epidermal growth factor receptor activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 190 | | GO:0016044 | membrane organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 191 | | GO:0030539 | male genitalia development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 192 | | GO:0031639 | plasminogen activation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 193 | | GO:0035229 | positive regulation of glutamate\-cysteine ligase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 194 | | GO:0051409 | response to nitrosative stress | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 195 | | GO:0051276 | chromosome organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 196 | | GO:0045950 | negative regulation of mitotic recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 197 | | GO:0046632 | alpha\-beta T cell differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 198 | | GO:0046641 | positive regulation of alpha\-beta T cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 199 | | GO:0051098 | regulation of binding | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 200 | | GO:0000085 | G2 phase of mitotic cell cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 201 | | GO:0031572 | G2/M transition DNA damage checkpoint | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 202 | | GO:0051782 | negative regulation of cell division | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 203 | | GO:0006066 | alcohol metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 204 | | GO:0009187 | cyclic nucleotide metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 205 | | GO:0051106 | positive regulation of DNA ligation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 206 | | GO:0000183 | chromatin silencing at rDNA | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 207 | | GO:0006348 | chromatin silencing at telomere | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 208 | | GO:0006980 | redox signal response | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 209 | | GO:0007096 | regulation of exit from mitosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 210 | | GO:0006266 | DNA ligation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 211 | | GO:0043043 | peptide biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 212 | | GO:0007016 | cytoskeletal anchoring | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 213 | | GO:0001953 | negative regulation of cell\-matrix adhesion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 214 | | GO:0002328 | pro\-B cell differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 215 | | GO:0033077 | T cell differentiation in the thymus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 216 | | GO:0033152 | immunoglobulin V(D)J recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 217 | | GO:0033153 | T cell receptor V(D)J recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 218 | | GO:0000389 | nuclear mRNA 3'\-splice site recognition | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 219 | | GO:0007021 | tubulin folding | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 220 | | GO:0006270 | DNA replication initiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 221 | | GO:0015979 | photosynthesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 222 | | GO:0015995 | chlorophyll biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 223 | | GO:0015919 | peroxisomal membrane transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 224 | | GO:0001777 | T cell homeostatic proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 225 | | GO:0001783 | B cell apoptosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 226 | | GO:0001844 | protein insertion into mitochondrial membrane during induction of apoptosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 227 | | GO:0002358 | B cell homeostatic proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 228 | | GO:0043281 | regulation of caspase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 229 | | GO:0006922 | cleavage of lamin | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 230 | | GO:0032976 | release of matrix enzymes from mitochondria | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 231 | | GO:0043653 | mitochondrial fragmentation during apoptosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 232 | | GO:0046674 | induction of retinal programmed cell death | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 233 | | GO:0060011 | Sertoli cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 234 | | GO:0008542 | visual learning | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 235 | | GO:0045749 | negative regulation of S phase of mitotic cell cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 236 | | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 237 | | GO:0001766 | membrane raft polarization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 238 | | GO:0007516 | hemocyte development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 239 | | GO:0045176 | apical protein localization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 240 | | GO:0006287 | base\-excision repair\, gap\-filling | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 241 | | GO:0006566 | threonine metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 242 | | GO:0007389 | pattern specification process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 243 | | GO:0048665 | neuron fate specification | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 244 | | GO:0006909 | phagocytosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 245 | | GO:0050922 | negative regulation of chemotaxis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 246 | | GO:0006084 | acetyl\-CoA metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 247 | | GO:0006564 | L\-serine biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 248 | | GO:0000076 | DNA replication checkpoint | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 249 | | GO:0009755 | hormone\-mediated signaling | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 250 | | GO:0006587 | serotonin biosynthetic process from tryptophan | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 251 | | GO:0042427 | serotonin biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 252 | | GO:0030833 | regulation of actin filament polymerization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 253 | | GO:0006626 | protein targeting to mitochondrion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 254 | | GO:0006583 | melanin biosynthetic process from tyrosine | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 255 | | GO:0006726 | eye pigment biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 256 | | GO:0042840 | D\-glucuronate catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 257 | | GO:0019853 | L\-ascorbic acid biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 258 | | GO:0046185 | aldehyde catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 259 | | GO:0001833 | inner cell mass cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 260 | | GO:0043009 | chordate embryonic development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 261 | | GO:0006978 | DNA damage response\, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 262 | | GO:0007090 | regulation of S phase of mitotic cell cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 263 | | GO:0007141 | male meiosis I | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 264 | | GO:0033205 | cytokinesis during cell cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 265 | | GO:0033595 | response to genistein | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 266 | | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 267 | | GO:0035264 | multicellular organism growth | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 268 | | GO:0051298 | centrosome duplication | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 269 | | GO:0008228 | opsonization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 270 | | GO:0022409 | positive regulation of cell\-cell adhesion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 271 | | GO:0010468 | regulation of gene expression | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 272 | | GO:0018350 | protein amino acid esterification | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 273 | | GO:0030157 | pancreatic juice secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 274 | | GO:0044258 | intestinal lipid catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 275 | | GO:0046514 | ceramide catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 276 | | GO:0006931 | substrate\-bound cell migration\, cell attachment to substrate | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 277 | | GO:0032023 | trypsinogen activation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 278 | | GO:0009117 | nucleotide metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 279 | | GO:0007030 | Golgi organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 280 | | GO:0006072 | glycerol\-3\-phosphate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 281 | | GO:0046168 | glycerol\-3\-phosphate catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 282 | | GO:0006288 | base\-excision repair\, DNA ligation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 283 | | GO:0017055 | negative regulation of transcriptional preinitiation complex assembly | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 284 | | GO:0006102 | isocitrate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 285 | | GO:0045663 | positive regulation of myoblast differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 286 | | GO:0043353 | enucleate erythrocyte differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 287 | | GO:0043030 | regulation of macrophage activation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 288 | | GO:0042773 | ATP synthesis coupled electron transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 289 | | GO:0046034 | ATP metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 290 | | GO:0001553 | luteinization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 291 | | GO:0008406 | gonad development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 292 | | GO:0007538 | primary sex determination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 293 | | GO:0050810 | regulation of steroid biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 294 | | GO:0006298 | mismatch repair | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 295 | | GO:0030224 | monocyte differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 296 | | GO:0000731 | DNA synthesis during DNA repair | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 297 | | GO:0000084 | S phase of mitotic cell cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 298 | | GO:0035308 | negative regulation of protein amino acid dephosphorylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 299 | | GO:0043666 | regulation of phosphoprotein phosphatase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 300 | | GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 301 | | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 302 | | GO:0015904 | tetracycline transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 303 | | GO:0046677 | response to antibiotic | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 304 | | GO:0046676 | negative regulation of insulin secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 305 | | GO:0032024 | positive regulation of insulin secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 306 | | GO:0006559 | L\-phenylalanine catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 307 | | GO:0006729 | tetrahydrobiopterin biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 308 | | GO:0051066 | dihydrobiopterin metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 309 | | GO:0006376 | mRNA splice site selection | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 310 | | GO:0065002 | intracellular protein transport across a membrane | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 311 | | GO:0001101 | response to acid | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 312 | | GO:0045056 | transcytosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 313 | | GO:0046628 | positive regulation of insulin receptor signaling pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 314 | | GO:0048011 | nerve growth factor receptor signaling pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 315 | | GO:0051385 | response to mineralocorticoid stimulus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 316 | | GO:0007217 | tachykinin signaling pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 317 | | GO:0007320 | insemination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 318 | | GO:0009582 | detection of abiotic stimulus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 319 | | GO:0032205 | negative regulation of telomere maintenance | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 320 | | GO:0042267 | natural killer cell mediated cytotoxicity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 321 | | GO:0051225 | spindle assembly | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 322 | | GO:0051246 | regulation of protein metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 323 | | GO:0006122 | mitochondrial electron transport\, ubiquinol to cytochrome c | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 324 | | GO:0007223 | Wnt receptor signaling pathway\, calcium modulating pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 325 | | GO:0030321 | transepithelial chloride transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 326 | | GO:0046785 | microtubule polymerization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 327 | | GO:0006801 | superoxide metabolic process | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 328 | | GO:0001836 | release of cytochrome c from mitochondria | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 329 | | GO:0045454 | cell redox homeostasis | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 330 | | GO:0016042 | lipid catabolic process | 5 | 394 | 11 | 544 | 4.52e-01 | 0.01 | 0.02 | 0.6 |
| 331 | | GO:0007569 | cell aging | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 332 | | GO:0009408 | response to heat | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 333 | | GO:0042493 | response to drug | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 334 | | GO:0045333 | cellular respiration | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 335 | | GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 336 | | GO:0007595 | lactation | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 337 | | GO:0006094 | gluconeogenesis | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 338 | | GO:0000082 | G1/S transition of mitotic cell cycle | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 339 | | GO:0006800 | oxygen and reactive oxygen species metabolic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 340 | | GO:0006334 | nucleosome assembly | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 341 | | GO:0008016 | regulation of heart contraction | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 342 | | GO:0045165 | cell fate commitment | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 343 | | GO:0019722 | calcium\-mediated signaling | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 344 | | GO:0007204 | elevation of cytosolic calcium ion concentration | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 345 | | GO:0006355 | regulation of transcription\, DNA\-dependent | 44 | 355 | 70 | 485 | 4.80e-01 | 0.11 | 0.13 | 0.9 |
| 346 | | GO:0001666 | response to hypoxia | 12 | 387 | 22 | 533 | 4.83e-01 | 0.03 | 0.04 | 0.8 |
| 347 | | GO:0030154 | cell differentiation | 13 | 386 | 24 | 531 | 4.97e-01 | 0.03 | 0.04 | 0.8 |
| 348 | | GO:0006809 | nitric oxide biosynthetic process | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 349 | | GO:0006813 | potassium ion transport | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 350 | | GO:0006974 | response to DNA damage stimulus | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 351 | | GO:0006357 | regulation of transcription from RNA polymerase II promoter | 11 | 388 | 11 | 544 | 5.13e-01 | 0.03 | 0.02 | 1.4 |
| 352 | | GO:0006917 | induction of apoptosis | 20 | 379 | 23 | 532 | 5.31e-01 | 0.05 | 0.04 | 1.2 |
| 353 | | GO:0007611 | learning and/or memory | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 354 | | GO:0016337 | cell\-cell adhesion | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 355 | | GO:0007517 | muscle development | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 356 | | GO:0006953 | acute\-phase response | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 357 | | GO:0001558 | regulation of cell growth | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 358 | | GO:0006633 | fatty acid biosynthetic process | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 359 | | GO:0050731 | positive regulation of peptidyl\-tyrosine phosphorylation | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 360 | | GO:0006309 | DNA fragmentation during apoptosis | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 361 | | GO:0045860 | positive regulation of protein kinase activity | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 362 | | GO:0042554 | superoxide release | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 363 | | GO:0042744 | hydrogen peroxide catabolic process | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 364 | | GO:0016481 | negative regulation of transcription | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 365 | | GO:0007050 | cell cycle arrest | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 366 | | GO:0007601 | visual perception | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 367 | | GO:0045893 | positive regulation of transcription\, DNA\-dependent | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 368 | | GO:0030036 | actin cytoskeleton organization and biogenesis | 4 | 395 | 9 | 546 | 5.74e-01 | 0.01 | 0.02 | 0.6 |
| 369 | | GO:0043473 | pigmentation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 370 | | GO:0030264 | nuclear fragmentation during apoptosis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 371 | | GO:0006927 | transformed cell apoptosis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 372 | | GO:0042062 | long\-term strengthening of neuromuscular junction | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 373 | | GO:0031116 | positive regulation of microtubule polymerization | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 374 | | GO:0018105 | peptidyl\-serine phosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 375 | | GO:0030163 | protein catabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 376 | | GO:0042311 | vasodilation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 377 | | GO:0006983 | ER overload response | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 378 | | GO:0048147 | negative regulation of fibroblast proliferation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 379 | | GO:0001963 | synaptic transmission\, dopaminergic | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 380 | | GO:0001933 | negative regulation of protein amino acid phosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 381 | | GO:0050900 | leukocyte migration | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 382 | | GO:0007568 | aging | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 383 | | GO:0015671 | oxygen transport | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 384 | | GO:0009650 | UV protection | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 385 | | GO:0046666 | retinal cell programmed cell death | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 386 | | GO:0042445 | hormone metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 387 | | GO:0008634 | negative regulation of survival gene product expression | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 388 | | GO:0009072 | aromatic amino acid family metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 389 | | GO:0030890 | positive regulation of B cell proliferation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 390 | | GO:0050727 | regulation of inflammatory response | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 391 | | GO:0006739 | NADP metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 392 | | GO:0031647 | regulation of protein stability | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 393 | | GO:0046855 | inositol phosphate dephosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 394 | | GO:0046856 | phosphoinositide dephosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 395 | | GO:0048738 | cardiac muscle development | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 396 | | GO:0051895 | negative regulation of focal adhesion formation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 397 | | GO:0051898 | negative regulation of protein kinase B signaling cascade | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 398 | | GO:0007266 | Rho protein signal transduction | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 399 | | GO:0008361 | regulation of cell size | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 400 | | GO:0030879 | mammary gland development | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 401 | | GO:0050708 | regulation of protein secretion | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 402 | | GO:0008088 | axon cargo transport | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 403 | | GO:0040009 | regulation of growth rate | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 404 | | GO:0018108 | peptidyl\-tyrosine phosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 405 | | GO:0030838 | positive regulation of actin filament polymerization | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 406 | | GO:0032436 | positive regulation of proteasomal ubiquitin\-dependent protein catabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 407 | | GO:0043280 | positive regulation of caspase activity | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 408 | | GO:0045079 | negative regulation of chemokine biosynthetic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 409 | | GO:0007031 | peroxisome organization and biogenesis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 410 | | GO:0006333 | chromatin assembly or disassembly | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 411 | | GO:0016310 | phosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 412 | | GO:0030325 | adrenal gland development | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 413 | | GO:0007088 | regulation of mitosis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 414 | | GO:0006950 | response to stress | 14 | 385 | 16 | 539 | 5.79e-01 | 0.04 | 0.03 | 1.2 |
| 415 | | GO:0006835 | dicarboxylic acid transport | 7 | 392 | 7 | 548 | 5.91e-01 | 0.02 | 0.01 | 1.4 |
| 416 | | GO:0007166 | cell surface receptor linked signal transduction | 13 | 386 | 22 | 533 | 6.05e-01 | 0.03 | 0.04 | 0.8 |
| 417 | | GO:0006464 | protein modification process | 8 | 391 | 8 | 547 | 6.11e-01 | 0.02 | 0.01 | 1.4 |
| 418 | | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 8 | 391 | 8 | 547 | 6.11e-01 | 0.02 | 0.01 | 1.4 |
| 419 | | GO:0006811 | ion transport | 14 | 385 | 24 | 531 | 6.16e-01 | 0.04 | 0.04 | 0.8 |
| 420 | | GO:0006928 | cell motility | 14 | 385 | 24 | 531 | 6.16e-01 | 0.04 | 0.04 | 0.8 |
| 421 | | GO:0006461 | protein complex assembly | 6 | 393 | 11 | 544 | 6.30e-01 | 0.02 | 0.02 | 0.8 |
| 422 | | GO:0007566 | embryo implantation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 423 | | GO:0019430 | removal of superoxide radicals | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 424 | | GO:0045892 | negative regulation of transcription\, DNA\-dependent | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 425 | | GO:0043193 | positive regulation of gene\-specific transcription | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 426 | | GO:0045596 | negative regulation of cell differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 427 | | GO:0007026 | negative regulation of microtubule depolymerization | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 428 | | GO:0007631 | feeding behavior | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 429 | | GO:0043691 | reverse cholesterol transport | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 430 | | GO:0046627 | negative regulation of insulin receptor signaling pathway | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 431 | | GO:0001919 | regulation of receptor recycling | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 432 | | GO:0007265 | Ras protein signal transduction | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 433 | | GO:0030168 | platelet activation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 434 | | GO:0009790 | embryonic development | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 435 | | GO:0045084 | positive regulation of interleukin\-12 biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 436 | | GO:0009395 | phospholipid catabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 437 | | GO:0007200 | G\-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 438 | | GO:0007628 | adult walking behavior | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 439 | | GO:0007548 | sex differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 440 | | GO:0006695 | cholesterol biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 441 | | GO:0046888 | negative regulation of hormone secretion | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 442 | | GO:0030238 | male sex determination | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 443 | | GO:0030574 | collagen catabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 444 | | GO:0045086 | positive regulation of interleukin\-2 biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 445 | | GO:0030334 | regulation of cell migration | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 446 | | GO:0006941 | striated muscle contraction | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 447 | | GO:0007512 | adult heart development | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 448 | | GO:0030049 | muscle filament sliding | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 449 | | GO:0055010 | ventricular cardiac muscle morphogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 450 | | GO:0007172 | signal complex assembly | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 451 | | GO:0007417 | central nervous system development | 7 | 392 | 13 | 542 | 6.49e-01 | 0.02 | 0.02 | 0.7 |
| 452 | | GO:0045736 | negative regulation of cyclin\-dependent protein kinase activity | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 453 | | GO:0007281 | germ cell development | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 454 | | GO:0048009 | insulin\-like growth factor receptor signaling pathway | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 455 | | GO:0008630 | DNA damage response\, signal transduction resulting in induction of apoptosis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 456 | | GO:0001937 | negative regulation of endothelial cell proliferation | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 457 | | GO:0016192 | vesicle\-mediated transport | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 458 | | GO:0042771 | DNA damage response\, signal transduction by p53 class mediator resulting in induction of apoptosis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 459 | | GO:0007612 | learning | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 460 | | GO:0001756 | somitogenesis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 461 | | GO:0042987 | amyloid precursor protein catabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 462 | | GO:0006265 | DNA topological change | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 463 | | GO:0043154 | negative regulation of caspase activity | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 464 | | GO:0009405 | pathogenesis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 465 | | GO:0050718 | positive regulation of interleukin\-1 beta secretion | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 466 | | GO:0000079 | regulation of cyclin\-dependent protein kinase activity | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 467 | | GO:0030182 | neuron differentiation | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 468 | | GO:0006812 | cation transport | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 469 | | GO:0007399 | nervous system development | 19 | 380 | 31 | 524 | 6.59e-01 | 0.05 | 0.06 | 0.9 |
| 470 | | GO:0043085 | positive regulation of catalytic activity | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 471 | | GO:0042542 | response to hydrogen peroxide | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 472 | | GO:0043434 | response to peptide hormone stimulus | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 473 | | GO:0045840 | positive regulation of mitosis | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 474 | | GO:0050715 | positive regulation of cytokine secretion | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 475 | | GO:0048167 | regulation of synaptic plasticity | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 476 | | GO:0043491 | protein kinase B signaling cascade | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 477 | | GO:0000302 | response to reactive oxygen species | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 478 | | GO:0008624 | induction of apoptosis by extracellular signals | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 479 | | GO:0050880 | regulation of blood vessel size | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 480 | | GO:0006839 | mitochondrial transport | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 481 | | GO:0048304 | positive regulation of isotype switching to IgG isotypes | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 482 | | GO:0044267 | cellular protein metabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 483 | | GO:0045110 | intermediate filament bundle assembly | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 484 | | GO:0030335 | positive regulation of cell migration | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 485 | | GO:0030307 | positive regulation of cell growth | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 486 | | GO:0042446 | hormone biosynthetic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 487 | | GO:0045604 | regulation of epidermal cell differentiation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 488 | | GO:0046330 | positive regulation of JNK cascade | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 489 | | GO:0042110 | T cell activation | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 490 | | GO:0007205 | activation of protein kinase C activity | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 491 | | GO:0030225 | macrophage differentiation | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 492 | | GO:0043410 | positive regulation of MAPKKK cascade | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 493 | | GO:0007160 | cell\-matrix adhesion | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 494 | | GO:0043123 | positive regulation of I\-kappaB kinase/NF\-kappaB cascade | 11 | 388 | 19 | 536 | 7.07e-01 | 0.03 | 0.03 | 0.8 |
| 495 | | GO:0006749 | glutathione metabolic process | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 496 | | GO:0045471 | response to ethanol | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 497 | | GO:0060052 | neurofilament cytoskeleton organization and biogenesis | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 498 | | GO:0006878 | cellular copper ion homeostasis | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 499 | | GO:0015813 | L\-glutamate transport | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 500 | | GO:0042640 | anagen | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 501 | | GO:0046777 | protein amino acid autophosphorylation | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 502 | | GO:0050896 | response to stimulus | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 503 | | GO:0016485 | protein processing | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 504 | | GO:0030900 | forebrain development | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 505 | | GO:0051591 | response to cAMP | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 506 | | GO:0007218 | neuropeptide signaling pathway | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 507 | | GO:0006959 | humoral immune response | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 508 | | GO:0001568 | blood vessel development | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 509 | | GO:0042632 | cholesterol homeostasis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 510 | | GO:0030593 | neutrophil chemotaxis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 511 | | GO:0030198 | extracellular matrix organization and biogenesis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 512 | | GO:0030097 | hemopoiesis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 513 | | GO:0007018 | microtubule\-based movement | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 514 | | GO:0009636 | response to toxin | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 515 | | GO:0006919 | caspase activation | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 516 | | GO:0045449 | regulation of transcription | 19 | 380 | 24 | 531 | 7.54e-01 | 0.05 | 0.04 | 1.1 |
| 517 | | GO:0015992 | proton transport | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 518 | | GO:0007565 | female pregnancy | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 519 | | GO:0000226 | microtubule cytoskeleton organization and biogenesis | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 520 | | GO:0030324 | lung development | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 521 | | GO:0042127 | regulation of cell proliferation | 6 | 393 | 7 | 548 | 7.82e-01 | 0.02 | 0.01 | 1.2 |
| 522 | | GO:0007264 | small GTPase mediated signal transduction | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 523 | | GO:0008219 | cell death | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 524 | | GO:0042309 | homoiothermy | 7 | 392 | 8 | 547 | 7.94e-01 | 0.02 | 0.01 | 1.2 |
| 525 | | GO:0050826 | response to freezing | 7 | 392 | 8 | 547 | 7.94e-01 | 0.02 | 0.01 | 1.2 |
| 526 | | GO:0006915 | apoptosis | 34 | 365 | 45 | 510 | 8.13e-01 | 0.09 | 0.08 | 1.1 |
| 527 | | GO:0043065 | positive regulation of apoptosis | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 528 | | GO:0007605 | sensory perception of sound | 10 | 389 | 12 | 543 | 8.28e-01 | 0.03 | 0.02 | 1.2 |
| 529 | | GO:0006366 | transcription from RNA polymerase II promoter | 10 | 389 | 12 | 543 | 8.28e-01 | 0.03 | 0.02 | 1.2 |
| 530 | | GO:0007268 | synaptic transmission | 18 | 381 | 24 | 531 | 8.75e-01 | 0.05 | 0.04 | 1.0 |
| 531 | | GO:0008152 | metabolic process | 25 | 374 | 33 | 522 | 8.91e-01 | 0.06 | 0.06 | 1.1 |
| 532 | | GO:0008283 | cell proliferation | 28 | 371 | 41 | 514 | 8.99e-01 | 0.07 | 0.07 | 0.9 |
| 533 | | GO:0000187 | activation of MAPK activity | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 534 | | GO:0045859 | regulation of protein kinase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 535 | | GO:0000303 | response to superoxide | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 536 | | GO:0001541 | ovarian follicle development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 537 | | GO:0001819 | positive regulation of cytokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 538 | | GO:0001890 | placenta development | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 539 | | GO:0001895 | retina homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 540 | | GO:0002262 | myeloid cell homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 541 | | GO:0007626 | locomotory behavior | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 542 | | GO:0019226 | transmission of nerve impulse | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 543 | | GO:0031667 | response to nutrient levels | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 544 | | GO:0032287 | myelin maintenance in the peripheral nervous system | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 545 | | GO:0033081 | regulation of T cell differentiation in the thymus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 546 | | GO:0040014 | regulation of multicellular organism growth | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 547 | | GO:0045541 | negative regulation of cholesterol biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 548 | | GO:0046620 | regulation of organ growth | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 549 | | GO:0046688 | response to copper ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 550 | | GO:0046716 | muscle maintenance | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 551 | | GO:0048538 | thymus development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 552 | | GO:0048678 | response to axon injury | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 553 | | GO:0050665 | hydrogen peroxide biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 554 | | GO:0060047 | heart contraction | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 555 | | GO:0060087 | relaxation of vascular smooth muscle | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 556 | | GO:0060088 | auditory receptor cell stereocilium organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 557 | | GO:0006091 | generation of precursor metabolites and energy | 12 | 387 | 16 | 539 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 558 | | GO:0015986 | ATP synthesis coupled proton transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 559 | | GO:0006897 | endocytosis | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 560 | | GO:0007219 | Notch signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 561 | | GO:0050905 | neuromuscular process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 562 | | GO:0001935 | endothelial cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 563 | | GO:0001974 | blood vessel remodeling | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 564 | | GO:0007199 | G\-protein signaling\, coupled to cGMP nucleotide second messenger | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 565 | | GO:0042742 | defense response to bacterium | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 566 | | GO:0048384 | retinoic acid receptor signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 567 | | GO:0050829 | defense response to Gram\-negative bacterium | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 568 | | GO:0001315 | age\-dependent response to reactive oxygen species | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 569 | | GO:0007584 | response to nutrient | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 570 | | GO:0009314 | response to radiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 571 | | GO:0010035 | response to inorganic substance | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 572 | | GO:0010039 | response to iron ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 573 | | GO:0031000 | response to caffeine | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 574 | | GO:0031069 | hair follicle morphogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 575 | | GO:0032848 | negative regulation of cellular pH reduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 576 | | GO:0035094 | response to nicotine | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 577 | | GO:0043627 | response to estrogen stimulus | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 578 | | GO:0045069 | regulation of viral genome replication | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 579 | | GO:0051607 | defense response to virus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 580 | | GO:0051902 | negative regulation of mitochondrial depolarization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 581 | | GO:0042100 | B cell proliferation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 582 | | GO:0045776 | negative regulation of blood pressure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 583 | | GO:0045822 | negative regulation of heart contraction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 584 | | GO:0001782 | B cell homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 585 | | GO:0007507 | heart development | 10 | 389 | 15 | 540 | 1.00e+00 | 0.03 | 0.03 | 0.9 |
| 586 | | GO:0008625 | induction of apoptosis via death domain receptors | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 587 | | GO:0008631 | induction of apoptosis by oxidative stress | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 588 | | GO:0030216 | keratinocyte differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 589 | | GO:0030889 | negative regulation of B cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 590 | | GO:0043029 | T cell homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 591 | | GO:0046007 | negative regulation of activated T cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 592 | | GO:0045083 | negative regulation of interleukin\-12 biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 593 | | GO:0000060 | protein import into nucleus\, translocation | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 594 | | GO:0001775 | cell activation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 595 | | GO:0001932 | regulation of protein amino acid phosphorylation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 596 | | GO:0002037 | negative regulation of L\-glutamate transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 597 | | GO:0007254 | JNK cascade | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 598 | | GO:0009612 | response to mechanical stimulus | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 599 | | GO:0043525 | positive regulation of neuron apoptosis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 600 | | GO:0045670 | regulation of osteoclast differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 601 | | GO:0045994 | positive regulation of translational initiation by iron | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 602 | | GO:0046325 | negative regulation of glucose import | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 603 | | GO:0050806 | positive regulation of synaptic transmission | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 604 | | GO:0051023 | regulation of immunoglobulin secretion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 605 | | GO:0051092 | activation of NF\-kappaB transcription factor | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 606 | | GO:0051222 | positive regulation of protein transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 607 | | GO:0002439 | chronic inflammatory response to antigenic stimulus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 608 | | GO:0050901 | leukocyte tethering or rolling | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 609 | | GO:0002740 | negative regulation of cytokine secretion during immune response | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 610 | | GO:0032715 | negative regulation of interleukin\-6 production | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 611 | | GO:0045071 | negative regulation of viral genome replication | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 612 | | GO:0042346 | positive regulation of NF\-kappaB import into nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 613 | | GO:0045080 | positive regulation of chemokine biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 614 | | GO:0032722 | positive regulation of chemokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 615 | | GO:0001934 | positive regulation of protein amino acid phosphorylation | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 616 | | GO:0048661 | positive regulation of smooth muscle cell proliferation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 617 | | GO:0032800 | receptor biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 618 | | GO:0051384 | response to glucocorticoid stimulus | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 619 | | GO:0033209 | tumor necrosis factor\-mediated signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 620 | | GO:0006412 | translation | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 621 | | GO:0007411 | axon guidance | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 622 | | GO:0016567 | protein ubiquitination | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 623 | | GO:0030433 | ER\-associated protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 624 | | GO:0009267 | cellular response to starvation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 625 | | GO:0010033 | response to organic substance | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 626 | | GO:0019836 | hemolysis by symbiont of host red blood cells | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 627 | | GO:0043072 | negative regulation of non\-apoptotic programmed cell death | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 628 | | GO:0046689 | response to mercury ion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 629 | | GO:0051659 | maintenance of mitochondrion localization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 630 | | GO:0000165 | MAPKKK cascade | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 631 | | GO:0019858 | cytosine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 632 | | GO:0031663 | lipopolysaccharide\-mediated signaling pathway | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 633 | | GO:0032496 | response to lipopolysaccharide | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 634 | | GO:0043330 | response to exogenous dsRNA | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 635 | | GO:0045773 | positive regulation of axon extension | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 636 | | GO:0048699 | generation of neurons | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 637 | | GO:0006101 | citrate metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 638 | | GO:0005977 | glycogen metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 639 | | GO:0005978 | glycogen biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 640 | | GO:0006417 | regulation of translation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 641 | | GO:0006924 | activated T cell apoptosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 642 | | GO:0008286 | insulin receptor signaling pathway | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 643 | | GO:0008643 | carbohydrate transport | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 644 | | GO:0009725 | response to hormone stimulus | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 645 | | GO:0015758 | glucose transport | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 646 | | GO:0040018 | positive regulation of multicellular organism growth | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 647 | | GO:0045884 | regulation of survival gene product expression | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 648 | | GO:0015680 | intracellular copper ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 649 | | GO:0015694 | mercury ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 650 | | GO:0051353 | positive regulation of oxidoreductase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 651 | | GO:0006364 | rRNA processing | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 652 | | GO:0006396 | RNA processing | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 653 | | GO:0007616 | long\-term memory | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 654 | | GO:0031623 | receptor internalization | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 655 | | GO:0030856 | regulation of epithelial cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 656 | | GO:0007405 | neuroblast proliferation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 657 | | GO:0007422 | peripheral nervous system development | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 658 | | GO:0050930 | induction of positive chemotaxis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 659 | | GO:0006788 | heme oxidation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 660 | | GO:0031670 | cellular response to nutrient | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 661 | | GO:0032764 | negative regulation of mast cell cytokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 662 | | GO:0042167 | heme catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 663 | | GO:0043305 | negative regulation of mast cell degranulation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 664 | | GO:0043392 | negative regulation of DNA binding | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 665 | | GO:0043433 | negative regulation of transcription factor activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 666 | | GO:0045768 | positive regulation of anti\-apoptosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 667 | | GO:0001657 | ureteric bud development | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 668 | | GO:0007406 | negative regulation of neuroblast proliferation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 669 | | GO:0007412 | axon target recognition | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 670 | | GO:0008038 | neuron recognition | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 671 | | GO:0014047 | glutamate secretion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 672 | | GO:0016358 | dendrite development | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 673 | | GO:0019222 | regulation of metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 674 | | GO:0021675 | nerve development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 675 | | GO:0042490 | mechanoreceptor differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 676 | | GO:0045666 | positive regulation of neuron differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 677 | | GO:0046668 | regulation of retinal cell programmed cell death | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 678 | | GO:0048839 | inner ear development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 679 | | GO:0032488 | Cdc42 protein signal transduction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 680 | | GO:0019934 | cGMP\-mediated signaling | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 681 | | GO:0006874 | cellular calcium ion homeostasis | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 682 | | GO:0006707 | cholesterol catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 683 | | GO:0033344 | cholesterol efflux | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 684 | | GO:0046907 | intracellular transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 685 | | GO:0042158 | lipoprotein biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 686 | | GO:0043407 | negative regulation of MAP kinase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 687 | | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 688 | | GO:0050728 | negative regulation of inflammatory response | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 689 | | GO:0010544 | negative regulation of platelet activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 690 | | GO:0007263 | nitric oxide mediated signal transduction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 691 | | GO:0030828 | positive regulation of cGMP biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 692 | | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 693 | | GO:0051000 | positive regulation of nitric\-oxide synthase activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 694 | | GO:0051262 | protein tetramerization | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 695 | | GO:0032801 | receptor catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 696 | | GO:0030516 | regulation of axon extension | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 697 | | GO:0048168 | regulation of neuronal synaptic plasticity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 698 | | GO:0007271 | synaptic transmission\, cholinergic | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 699 | | GO:0006641 | triacylglycerol metabolic process | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 700 | | GO:0045664 | regulation of neuron differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 701 | | GO:0046928 | regulation of neurotransmitter secretion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 702 | | GO:0019233 | sensory perception of pain | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 703 | | GO:0001701 | in utero embryonic development | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 704 | | GO:0009792 | embryonic development ending in birth or egg hatching | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 705 | | GO:0008156 | negative regulation of DNA replication | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 706 | | GO:0030308 | negative regulation of cell growth | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 707 | | GO:0031571 | G1 DNA damage checkpoint | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 708 | | GO:0042149 | cellular response to glucose starvation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 709 | | GO:0051097 | negative regulation of helicase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 710 | | GO:0051453 | regulation of intracellular pH | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 711 | | GO:0018144 | RNA\-protein covalent cross\-linking | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 712 | | GO:0002347 | response to tumor cell | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 713 | | GO:0006306 | DNA methylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 714 | | GO:0009987 | cellular process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 715 | | GO:0031953 | negative regulation of protein amino acid autophosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 716 | | GO:0035026 | leading edge cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 717 | | GO:0006096 | glycolysis | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 718 | | GO:0006725 | aromatic compound metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 719 | | GO:0008210 | estrogen metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 720 | | GO:0000910 | cytokinesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 721 | | GO:0010155 | regulation of proton transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 722 | | GO:0043012 | regulation of fusion of sperm to egg plasma membrane | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 723 | | GO:0050663 | cytokine secretion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 724 | | GO:0006644 | phospholipid metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 725 | | GO:0042416 | dopamine biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 726 | | GO:0051926 | negative regulation of calcium ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 727 | | GO:0051346 | negative regulation of hydrolase activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 728 | | GO:0043267 | negative regulation of potassium ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 729 | | GO:0048662 | negative regulation of smooth muscle cell proliferation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 730 | | GO:0001542 | ovulation from ovarian follicle | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 731 | | GO:0002028 | regulation of sodium ion transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 732 | | GO:0000188 | inactivation of MAPK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 733 | | GO:0006469 | negative regulation of protein kinase activity | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 734 | | GO:0002026 | regulation of the force of heart contraction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 735 | | GO:0006937 | regulation of muscle contraction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 736 | | GO:0050730 | regulation of peptidyl\-tyrosine phosphorylation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 737 | | GO:0001708 | cell fate specification | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 738 | | GO:0001764 | neuron migration | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 739 | | GO:0006509 | membrane protein ectodomain proteolysis | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 740 | | GO:0007059 | chromosome segregation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 741 | | GO:0007220 | Notch receptor processing | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 742 | | GO:0007613 | memory | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 743 | | GO:0030326 | embryonic limb morphogenesis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 744 | | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 745 | | GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 746 | | GO:0001570 | vasculogenesis | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 747 | | GO:0009967 | positive regulation of signal transduction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 748 | | GO:0016477 | cell migration | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 749 | | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 750 | | GO:0043117 | positive regulation of vascular permeability | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 751 | | GO:0045779 | negative regulation of bone resorption | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 752 | | GO:0048255 | mRNA stabilization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 753 | | GO:0048286 | alveolus development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 754 | | GO:0001660 | fever | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 755 | | GO:0032755 | positive regulation of interleukin\-6 production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 756 | | GO:0045410 | positive regulation of interleukin\-6 biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 757 | | GO:0051091 | positive regulation of transcription factor activity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 758 | | GO:0019538 | protein metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 759 | | GO:0006744 | ubiquinone biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 760 | | GO:0001505 | regulation of neurotransmitter levels | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 761 | | GO:0006542 | glutamine biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 762 | | GO:0006807 | nitrogen compound metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 763 | | GO:0010226 | response to lithium ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 764 | | GO:0045184 | establishment of protein localization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 765 | | GO:0051966 | regulation of synaptic transmission\, glutamatergic | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 766 | | GO:0030185 | nitric oxide transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 767 | | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 768 | | GO:0030091 | protein repair | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 769 | | GO:0016043 | cellular component organization and biogenesis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 770 | | GO:0040029 | regulation of gene expression\, epigenetic | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 771 | | GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 772 | | GO:0010269 | response to selenium ion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 773 | | GO:0009441 | glycolate metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 774 | | GO:0033143 | regulation of steroid hormone receptor signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 775 | | GO:0030166 | proteoglycan biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 776 | | GO:0001843 | neural tube closure | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 777 | | GO:0006952 | defense response | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 778 | | GO:0007258 | JUN phosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 779 | | GO:0015867 | ATP transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 780 | | GO:0006826 | iron ion transport | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 781 | | GO:0014070 | response to organic cyclic substance | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 782 | | GO:0015682 | ferric iron transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 783 | | GO:0031643 | positive regulation of myelination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 784 | | GO:0006081 | aldehyde metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 785 | | GO:0001967 | suckling behavior | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 786 | | GO:0007617 | mating behavior | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 787 | | GO:0030901 | midbrain development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 788 | | GO:0050885 | neuromuscular process controlling balance | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 789 | | GO:0008033 | tRNA processing | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 790 | | GO:0007610 | behavior | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 791 | | GO:0001781 | neutrophil apoptosis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 792 | | GO:0006925 | inflammatory cell apoptosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 793 | | GO:0030968 | unfolded protein response | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 794 | | GO:0031642 | negative regulation of myelination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 795 | | GO:0045348 | positive regulation of MHC class II biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 796 | | GO:0050776 | regulation of immune response | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 797 | | GO:0032735 | positive regulation of interleukin\-12 production | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 798 | | GO:0006585 | dopamine biosynthetic process from tyrosine | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 799 | | GO:0042423 | catecholamine biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 800 | | GO:0009653 | anatomical structure morphogenesis | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 801 | | GO:0042755 | eating behavior | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 802 | | GO:0048545 | response to steroid hormone stimulus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 803 | | GO:0045995 | regulation of embryonic development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 804 | | GO:0001755 | neural crest cell migration | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 805 | | GO:0001759 | induction of an organ | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 806 | | GO:0001941 | postsynaptic membrane organization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 807 | | GO:0030432 | peristalsis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 808 | | GO:0031175 | neurite development | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 809 | | GO:0051584 | regulation of dopamine uptake | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 810 | | GO:0000086 | G2/M transition of mitotic cell cycle | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 811 | | GO:0001504 | neurotransmitter uptake | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 812 | | GO:0006182 | cGMP biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 813 | | GO:0009190 | cyclic nucleotide biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 814 | | GO:0007168 | receptor guanylyl cyclase signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 815 | | GO:0019371 | cyclooxygenase pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 816 | | GO:0007519 | skeletal muscle development | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 817 | | GO:0016575 | histone deacetylation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 818 | | GO:0006662 | glycerol ether metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 819 | | GO:0006986 | response to unfolded protein | 6 | 393 | 9 | 546 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 820 | | GO:0030150 | protein import into mitochondrial matrix | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 821 | | GO:0009239 | enterobactin biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 822 | | GO:0014012 | axon regeneration in the peripheral nervous system | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 823 | | GO:0048812 | neurite morphogenesis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 824 | | GO:0031133 | regulation of axon diameter | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 825 | | GO:0040011 | locomotion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 826 | | GO:0045109 | intermediate filament organization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 827 | | GO:0050772 | positive regulation of axonogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 828 | | GO:0008089 | anterograde axon cargo transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 829 | | GO:0019896 | axon transport of mitochondrion | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 830 | | GO:0033693 | neurofilament bundle assembly | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 831 | | GO:0008090 | retrograde axon cargo transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 832 | | GO:0030336 | negative regulation of cell migration | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 833 | | GO:0043542 | endothelial cell migration | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 834 | | GO:0006746 | FADH2 metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 835 | | GO:0002456 | T cell mediated immunity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 836 | | GO:0045065 | cytotoxic T cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 837 | | GO:0050850 | positive regulation of calcium\-mediated signaling | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 838 | | GO:0006886 | intracellular protein transport | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 839 | | GO:0015031 | protein transport | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 840 | | GO:0006913 | nucleocytoplasmic transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 841 | | GO:0007409 | axonogenesis | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 842 | | GO:0021983 | pituitary gland development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 843 | | GO:0046887 | positive regulation of hormone secretion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 844 | | GO:0044262 | cellular carbohydrate metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 845 | | GO:0006418 | tRNA aminoacylation for protein translation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 846 | | GO:0006427 | histidyl\-tRNA aminoacylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 847 | | GO:0006611 | protein export from nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 848 | | GO:0001817 | regulation of cytokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 849 | | GO:0050860 | negative regulation of T cell receptor signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 850 | | GO:0007525 | somatic muscle development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 851 | | GO:0042177 | negative regulation of protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 852 | | GO:0045908 | negative regulation of vasodilation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 853 | | GO:0045909 | positive regulation of vasodilation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 854 | | GO:0046631 | alpha\-beta T cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 855 | | GO:0007041 | lysosomal transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 856 | | GO:0008206 | bile acid metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 857 | | GO:0046686 | response to cadmium ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 858 | | GO:0001662 | behavioral fear response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 859 | | GO:0001881 | receptor recycling | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 860 | | GO:0007528 | neuromuscular junction development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 861 | | GO:0016050 | vesicle organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 862 | | GO:0016197 | endosome transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 863 | | GO:0032313 | regulation of Rab GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 864 | | GO:0035023 | regulation of Rho protein signal transduction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 865 | | GO:0035249 | synaptic transmission\, glutamatergic | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 866 | | GO:0051036 | regulation of endosome size | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 867 | | GO:0007032 | endosome organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 868 | | GO:0032855 | positive regulation of Rac GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 869 | | GO:0035022 | positive regulation of Rac protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 870 | | GO:0001503 | ossification | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 871 | | GO:0006817 | phosphate transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 872 | | GO:0031960 | response to corticosteroid stimulus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 873 | | GO:0006308 | DNA catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 874 | | GO:0006367 | transcription initiation from RNA polymerase II promoter | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 875 | | GO:0009083 | branched chain family amino acid catabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 876 | | GO:0042552 | myelination | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 877 | | GO:0045687 | positive regulation of glial cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 878 | | GO:0050804 | regulation of synaptic transmission | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 879 | | GO:0009268 | response to pH | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 880 | | GO:0045980 | negative regulation of nucleotide metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 881 | | GO:0051289 | protein homotetramerization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 882 | | GO:0007213 | acetylcholine receptor signaling\, muscarinic pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 883 | | GO:0007274 | neuromuscular synaptic transmission | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 884 | | GO:0000186 | activation of MAPKK activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 885 | | GO:0045741 | positive regulation of epidermal growth factor receptor activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 886 | | GO:0021940 | positive regulation of granule cell precursor proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 887 | | GO:0042327 | positive regulation of phosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 888 | | GO:0019933 | cAMP\-mediated signaling | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 889 | | GO:0046836 | glycolipid transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 890 | | GO:0032367 | intracellular cholesterol transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 891 | | GO:0015914 | phospholipid transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 892 | | GO:0019747 | regulation of isoprenoid metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 893 | | GO:0042345 | regulation of NF\-kappaB import into nucleus | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 894 | | GO:0006512 | ubiquitin cycle | 7 | 392 | 9 | 546 | 1.00e+00 | 0.02 | 0.02 | 1.1 |
| 895 | | GO:0006836 | neurotransmitter transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 896 | | GO:0007608 | sensory perception of smell | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 897 | | GO:0015844 | monoamine transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 898 | | GO:0015872 | dopamine transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 899 | | GO:0021984 | adenohypophysis development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 900 | | GO:0042053 | regulation of dopamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 901 | | GO:0042420 | dopamine catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 902 | | GO:0060134 | prepulse inhibition | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 903 | | GO:0050779 | RNA destabilization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 904 | | GO:0006511 | ubiquitin\-dependent protein catabolic process | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 905 | | GO:0016579 | protein deubiquitination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 906 | | GO:0051101 | regulation of DNA binding | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 907 | | GO:0006816 | calcium ion transport | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 908 | | GO:0006972 | hyperosmotic response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 909 | | GO:0030032 | lamellipodium biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 910 | | GO:0030041 | actin filament polymerization | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 911 | | GO:0031529 | ruffle organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 912 | | GO:0035025 | positive regulation of Rho protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 913 | | GO:0043552 | positive regulation of phosphoinositide 3\-kinase activity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 914 | | GO:0045453 | bone resorption | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 915 | | GO:0048261 | negative regulation of receptor\-mediated endocytosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 916 | | GO:0001841 | neural tube formation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 917 | | GO:0016068 | type I hypersensitivity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 918 | | GO:0008584 | male gonad development | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 919 | | GO:0019102 | male somatic sex determination | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 920 | | GO:0030521 | androgen receptor signaling pathway | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 921 | | GO:0030850 | prostate gland development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 922 | | GO:0001659 | temperature homeostasis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 923 | | GO:0001678 | cellular glucose homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 924 | | GO:0007005 | mitochondrion organization and biogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 925 | | GO:0019395 | fatty acid oxidation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 926 | | GO:0035066 | positive regulation of histone acetylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 927 | | GO:0042594 | response to starvation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 928 | | GO:0045722 | positive regulation of gluconeogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 929 | | GO:0046321 | positive regulation of fatty acid oxidation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 930 | | GO:0050821 | protein stabilization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 931 | | GO:0050873 | brown fat cell differentiation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 932 | | GO:0043526 | neuroprotection | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 933 | | GO:0043588 | skin development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 934 | | GO:0007154 | cell communication | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 935 | | GO:0006044 | N\-acetylglucosamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 936 | | GO:0006486 | protein amino acid glycosylation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 937 | | GO:0006688 | glycosphingolipid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 938 | | GO:0016051 | carbohydrate biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 939 | | GO:0015810 | aspartate transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 940 | | GO:0044237 | cellular metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 941 | | GO:0051259 | protein oligomerization | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 942 | | GO:0000209 | protein polyubiquitination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 943 | | GO:0030579 | ubiquitin\-dependent SMAD protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 944 | | GO:0031398 | positive regulation of protein ubiquitination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 945 | | GO:0031943 | regulation of glucocorticoid metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 946 | | GO:0043161 | proteasomal ubiquitin\-dependent protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 947 | | GO:0051604 | protein maturation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 948 | | GO:0006378 | mRNA polyadenylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 949 | | GO:0006379 | mRNA cleavage | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 950 | | GO:0006493 | protein amino acid O\-linked glycosylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 951 | | GO:0006584 | catecholamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 952 | | GO:0051260 | protein homooligomerization | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 953 | | GO:0051301 | cell division | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 954 | | GO:0007067 | mitosis | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 955 | | GO:0045843 | negative regulation of striated muscle development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 956 | | GO:0006857 | oligopeptide transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 957 | | GO:0007156 | homophilic cell adhesion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 958 | | GO:0016339 | calcium\-dependent cell\-cell adhesion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 959 | | GO:0045213 | neurotransmitter receptor metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 960 | | GO:0042832 | defense response to protozoan | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 961 | | GO:0045630 | positive regulation of T\-helper 2 cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 962 | | GO:0033138 | positive regulation of peptidyl\-serine phosphorylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 963 | | GO:0045727 | positive regulation of translation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 964 | | GO:0001816 | cytokine production | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 965 | | GO:0030183 | B cell differentiation | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 966 | | GO:0045671 | negative regulation of osteoclast differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 967 | | GO:0000245 | spliceosome assembly | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 968 | | GO:0006621 | protein retention in ER | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 969 | | GO:0001543 | ovarian follicle rupture | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 970 | | GO:0001658 | ureteric bud branching | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 971 | | GO:0001822 | kidney development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 972 | | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 973 | | GO:0001999 | renal response to blood flow during renin\-angiotensin regulation of systemic arterial blood pressure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 974 | | GO:0002018 | renin\-angiotensin regulation of aldosterone production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 975 | | GO:0002019 | regulation of renal output by angiotensin | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 976 | | GO:0002035 | brain renin\-angiotensin system | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 977 | | GO:0008065 | establishment of blood\-nerve barrier | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 978 | | GO:0042756 | drinking behavior | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 979 | | GO:0045723 | positive regulation of fatty acid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 980 | | GO:0046622 | positive regulation of organ growth | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 981 | | GO:0048143 | astrocyte activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 982 | | GO:0048659 | smooth muscle cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 983 | | GO:0051145 | smooth muscle cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 984 | | GO:0006691 | leukotriene metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 985 | | GO:0045785 | positive regulation of cell adhesion | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 986 | | GO:0006171 | cAMP biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 987 | | GO:0030263 | apoptotic chromosome condensation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 988 | | GO:0006304 | DNA modification | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 989 | | GO:0042335 | cuticle development | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 990 | | GO:0043406 | positive regulation of MAP kinase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 991 | | GO:0045415 | negative regulation of interleukin\-8 biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 992 | | GO:0045416 | positive regulation of interleukin\-8 biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 993 | | GO:0000902 | cell morphogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 994 | | GO:0006805 | xenobiotic metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 995 | | GO:0008652 | amino acid biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 996 | | GO:0007398 | ectoderm development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 997 | | GO:0021506 | anterior neuropore closure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 998 | | GO:0048701 | embryonic cranial skeleton morphogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 999 | | GO:0048705 | skeletal morphogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1000 | | GO:0001955 | blood vessel maturation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1001 | | GO:0006820 | anion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1002 | | GO:0032374 | regulation of cholesterol transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1003 | | GO:0006649 | phospholipid transfer to membrane | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1004 | | GO:0007603 | phototransduction\, visible light | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1005 | | GO:0045494 | photoreceptor cell maintenance | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1006 | | GO:0009308 | amine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1007 | | GO:0008610 | lipid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1008 | | GO:0001556 | oocyte maturation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1009 | | GO:0010225 | response to UV\-C | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1010 | | GO:0045088 | regulation of innate immune response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1011 | | GO:0045931 | positive regulation of mitotic cell cycle | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1012 | | GO:0000747 | conjugation with cellular fusion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1013 | | GO:0045058 | T cell selection | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1014 | | GO:0050870 | positive regulation of T cell activation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1015 | | GO:0050766 | positive regulation of phagocytosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1016 | | GO:0030299 | cholesterol absorption | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1017 | | GO:0006704 | glucocorticoid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1018 | | GO:0007567 | parturition | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1019 | | GO:0001954 | positive regulation of cell\-matrix adhesion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1020 | | GO:0030278 | regulation of ossification | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1021 | | GO:0042488 | positive regulation of odontogenesis of dentine\-containing teeth | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1022 | | GO:0045672 | positive regulation of osteoclast differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1023 | | GO:0046579 | positive regulation of Ras protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1024 | | GO:0030218 | erythrocyte differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1025 | | GO:0043249 | erythrocyte maturation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1026 | | GO:0008045 | motor axon guidance | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1027 | | GO:0001569 | patterning of blood vessels | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1028 | | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1029 | | GO:0006541 | glutamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1030 | | GO:0006543 | glutamine catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1031 | | GO:0045745 | positive regulation of G\-protein coupled receptor protein signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1032 | | GO:0060037 | pharyngeal system development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1033 | | GO:0042026 | protein refolding | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1034 | | GO:0009968 | negative regulation of signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1035 | | GO:0002237 | response to molecule of bacterial origin | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1036 | | GO:0007253 | cytoplasmic sequestering of NF\-kappaB | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1037 | | GO:0030595 | leukocyte chemotaxis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1038 | | GO:0030886 | negative regulation of myeloid dendritic cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1039 | | GO:0032695 | negative regulation of interleukin\-12 production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1040 | | GO:0042092 | T\-helper 2 type immune response | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1041 | | GO:0042130 | negative regulation of T cell proliferation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1042 | | GO:0045191 | regulation of isotype switching | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1043 | | GO:0045347 | negative regulation of MHC class II biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1044 | | GO:0045355 | negative regulation of interferon\-alpha biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1045 | | GO:0030101 | natural killer cell activation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1046 | | GO:0030217 | T cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1047 | | GO:0042104 | positive regulation of activated T cell proliferation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1048 | | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1049 | | GO:0046013 | regulation of T cell homeostatic proliferation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1050 | | GO:0050672 | negative regulation of lymphocyte proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1051 | | GO:0051024 | positive regulation of immunoglobulin secretion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1052 | | GO:0042102 | positive regulation of T cell proliferation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1053 | | GO:0045189 | connective tissue growth factor biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1054 | | GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1055 | | GO:0045446 | endothelial cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1056 | | GO:0000185 | activation of MAPKKK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1057 | | GO:0030534 | adult behavior | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1058 | | GO:0030641 | regulation of cellular pH | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1059 | | GO:0007257 | activation of JNK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1060 | | GO:0042060 | wound healing | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1061 | | GO:0043010 | camera\-type eye development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1062 | | GO:0001516 | prostaglandin biosynthetic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1063 | | GO:0006555 | methionine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1064 | | GO:0009058 | biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1065 | | GO:0009086 | methionine biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1066 | | GO:0008360 | regulation of cell shape | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1067 | | GO:0030048 | actin filament\-based movement | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1068 | | GO:0002027 | regulation of heart rate | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1069 | | GO:0006200 | ATP catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1070 | | GO:0045638 | negative regulation of myeloid cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1071 | | GO:0045746 | negative regulation of Notch signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1072 | | GO:0009595 | detection of biotic stimulus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1073 | | GO:0032088 | inhibition of NF\-kappaB transcription factor | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1074 | | GO:0042347 | negative regulation of NF\-kappaB import into nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1075 | | GO:0051457 | maintenance of protein localization in nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1076 | | GO:0018401 | peptidyl\-proline hydroxylation to 4\-hydroxy\-L\-proline | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1077 | | GO:0042787 | protein ubiquitination during ubiquitin\-dependent protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1078 | | GO:0030099 | myeloid cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1079 | | GO:0035307 | positive regulation of protein amino acid dephosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1080 | | GO:0001707 | mesoderm formation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1081 | | GO:0000398 | nuclear mRNA splicing\, via spliceosome | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1082 | | GO:0045104 | intermediate filament cytoskeleton organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1083 | | GO:0006261 | DNA\-dependent DNA replication | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1084 | | GO:0015695 | organic cation transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1085 | | GO:0045817 | positive regulation of transcription from RNA polymerase II promoter\, global | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1086 | | GO:0006002 | fructose 6\-phosphate metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1087 | | GO:0006110 | regulation of glycolysis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1088 | | GO:0030388 | fructose 1\,6\-bisphosphate metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1089 | | GO:0045987 | positive regulation of smooth muscle contraction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1090 | | GO:0046521 | sphingoid catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1091 | | GO:0006670 | sphingosine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1092 | | GO:0007635 | chemosensory behavior | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1093 | | GO:0007017 | microtubule\-based process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1094 | | GO:0051258 | protein polymerization | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1095 | | GO:0019048 | virus\-host interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1096 | | GO:0045070 | positive regulation of viral genome replication | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1097 | | GO:0030317 | sperm motility | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |